BioSpace News Archive

VBI Vaccines Inc. (NASDAQ: VBIV) (“VBI”), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced a collaboration with the National Research Council of Canada (NRC), Canada’s largest federal research and development organization, to develop a pan-coronavirus vaccine candidate, targeting COVID-19, severe acute respirat

As coronavirus cases surge nationwide, retail pharmacies are facing incredibly difficult circumstances: they must continue to dispense vital medications to their patients, and fight the spread of COVID-19 -- while keeping both employees and patients as safe as possible.

Bellerophon Therapeutics, Inc. (Nasdaq: BLPH), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, announced that it will host an investor conference call and webcast on the INOpulse® inhaled nitric oxide system (iNO) for the treatment of COVID-19 at 1:00 PM EDT.

ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, announced today that it has notified the U.S. Food and Drug Administration (FDA) of its intent to distribute the Company’s SARS-CoV-2 (COVID-19) IgM/IgG Antibody Fast Detection Kit intended for professional use, which delivers results in less than 10 minutes at the point-of-care

Relmada Therapeutics, Inc. (Nasdaq: RLMD), a clinical-stage company developing novel therapies for the treatment of central nervous system (CNS) diseases, today announced the appointment of Marc de Somer, MD, MBA, ScD, MPH, MSc, as Senior Vice President, Clinical Development and Safety.

Amyris, Inc., a global science and technology leader of pure, sustainable ingredients for the Health & Wellness, Clean Beauty and Flavors & Fragrances markets, announced that initial production of its hand sanitizer has started with Allure Labs as its contract manufacturing and packaging partner.

International medical imaging IT and cybersecurity company Sectra will install the radiology and breast imaging modules of its enterprise imaging solution at MetroHealth.

BioSig Technologies, Inc. announced that it appointed Jerome Zeldis, M.D., Ph.D as Executive Chair of ViralClear Pharmaceuticals, Inc., a new division within its majority-owned subsidiary NeuroClear Technologies, Inc., which recently acquired the rights to develop a novel pharmaceutical to treat Coronavirus Disease 2019.

Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced meaningful developments in its initial COVID-19 solutions and is launching the following: a COVID-19 Registry, Dashboard, and Capacity Planning Tool, with a new set of Financial Impact Planning Resources in development.

Primary PartnerCare® is saddened to announce the death of Tomas Pattugalan, MD, from COVID-19.